Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin alpha-1 (PCDHA1) is a protein encoded by the PCDHA1 gene, part of the protocadherin alpha gene cluster located on chromosome 5. It belongs to the cadherin superfamily and is one of several neural cell adhesion proteins that are integral plasma membrane proteins. These proteins likely play a critical role in the establishment and function of specific cell-cell connections in the brain, providing diversity and specificity to neuronal connectivity through homophilic interactions between their extracellular cadherin domains. The protein is organized with six extracellular cadherin domains, a single transmembrane segment, and a cytoplasmic tail. Its expression and alternative splicing are implicated in the molecular basis of neural circuit assembly, with disease associations noted in prostate cancer and autism spectrum disorder, possibly due to its role in neural development and network formation.
Not applicable. No drugs target this molecule or receptor directly, so no mechanisms of action are described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin alpha-1 (PCDHA1).